story of the week
Attrition Between Lines of Therapy and Real-World Outcomes in Patients With HER2-Positive Metastatic Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Breast Cancer Research and Treatment
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Attrition between lines of therapy and real-world outcomes of patients with HER2-positive metastatic breast cancer in Europe: a cohort study leveraging electronic medical records
Breast Cancer Res Treat 2024 Oct 20;[EPub Ahead of Print], P Cottu, S Cheeseman, P Hall, A Wöckel, CW Scholz, E Bria, A Orlandi, N Ribelles, M Vallet, N Niklas, C Hogg, S Aggarwal, J Moreira, M Lucerna, SM Collin, A Logue, GH LongFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.